UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer

Pursuant to Rules 13a-16 or 15d-16 under

the Securities Exchange Act of 1934

For the month of December 2025

Commission File Number: 001-38836

BIOCERES CROP SOLUTIONS CORP.

(Translation of registrant’s name into English)

Ocampo 210 bis, Predio CCT, Rosario

Province of Santa Fe, Argentina

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F x                               Form 40-F ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

EXPLANATORY NOTE

This Form 6-K is incorporated by reference into the Company’s registration statements on Form F-3 (Registration No. 333-284195) and Form S-8 (Registration Nos. 333-271941 and 333-266333).

~~Court~~Bioceres ~~Decision~~Crop inSolutions Announces ~~Litigation~~Appointment ~~with~~of ~~Noteholders~~Chief Financial Officer and Changes to Board of Directors

Bioceres Crop Solutions Corp. (the “Company”) ~~informs~~today ~~that,~~announced onthe ~~December~~appointment ~~18,~~of ~~2025,~~its ~~proceedings~~chief ~~were~~financial ~~held~~officer inand ~~the~~changes ~~Commercial~~to ~~Division~~the composition of the ~~Supreme Court~~board of ~~the~~directors ~~State~~ of ~~New~~the ~~York~~Company ~~for New York County in Jasper Lake Ventures One LLC, et al. v. Bioceres Crop Solutions Corp., et al.~~ (~~Index No. 659704/2025) (~~the “~~Action~~Board of Directors”).

OnEzequiel ~~November~~Simmermacher ~~11, 2025, Jasper~~is ~~Lake~~being ~~Ventures~~appointed ~~One~~as ~~LLC, Redwood Enhanced Income Corp., Liminality Partners LP, and Solel-Bioceres SPV, L.P. (collectively,~~ the ~~“Plaintiffs”) filed claims against the~~ Company’s ~~and~~chief ~~certain~~financial ~~affiliated entities (collectively~~officer, ~~the~~with ~~“Defendants”)~~effect ~~arising~~ from ~~alleged~~January ~~defaults under the notes issued and outstanding under that certain Convertible Note Purchase Agreement dated August~~ 5, ~~2022 (as amended by the First Amendment to Note Purchase Agreement dated June 18~~2025, ~~2025)~~ and ~~the~~Duraiswami ~~Non-Convertible Note Purchase Agreement dated August 5, 2022~~ (~~as amended by the First Amendment to Note Purchase Agreement dated June 18, 2025) (the~~ “~~Notes~~D”)~~. The Company disputes the alleged~~ ~~defaults.~~Narain Onhas ~~November~~been ~~26,~~appointed ~~2025,~~as ~~the Plaintiffs filed~~ a ~~motion~~member byof ~~order to show cause in~~ the ~~Action~~Board seeking to enjoin Defendants from dissipating the collateral pledged in connection with the Notes. Defendants opposed the Plaintiffs’ requested relief and filed a cross-motion by order to show cause to enjoin the foreclosure auction of ~~the pledged collateral noticed by the Plaintiffs for December 22~~Directors, ~~2025.~~effective On December 1829, 2025~~, the Court denied the Defendants’ cross-motion and granted the Plaintiffs’ motion in part, ordering that the Defendants, namely the Company, Pro Farm Group, Inc~~., Pro Farm Michigan Manufacturing, LLC, Pro Farm Technologies Comércio de Insumos do Brasil Ltda., Pro Farm OU, and Pro Farm, Inc., “shall not transfer, convey, pledge, encumber, or otherwise dissipate any collateral or security interest” as defined in the governing pledge and security agreements.

~~Following~~Mr. ~~the~~Simmermacher ~~decision,~~has served ~~the~~as ~~Plaintiffs~~director ~~proposed~~of tooperational ~~adjourn~~excellence ~~the~~& ~~foreclosure~~business ~~sale~~development ~~previously~~for ~~scheduled~~South ~~for~~America ~~December~~at ~~22,~~CHS ~~2025,~~Inc. tosince ~~January~~2024. ~~19,~~In ~~2026~~this role, tohe ~~allow~~oversaw the ~~for~~design aand ~~more~~execution ~~orderly~~of ~~and~~strategic ~~commercially~~growth ~~reasonable~~initiatives ~~sale~~for ~~process~~South America. OnMr. ~~December~~Simmermacher ~~20,~~previously ~~2025,~~served ~~the~~as ~~Company~~regional ~~agreed~~finance director for South America at CHS Inc. from 2022 to 2024 and as chief financial officer for the ~~requested~~Southern ~~adjournment~~cone region (comprising Argentina, Paraguay and Uruguay) from 2016 to ~~cooperate~~2022 ~~with~~and ~~the~~other ~~sale~~finance ~~process~~roles toat ~~maximize~~CHS ~~value~~Inc. ~~The~~since ~~Company’s~~2012. ~~agreement~~Prior to ~~cooperate~~joining ~~with~~CHS ~~the~~Inc., ~~sale~~Mr. ~~process~~Simmermacher ~~includes~~worked at Monsanto and other agribusiness ~~providing~~companies ~~prospective~~in ~~bidders~~Argentina. ~~with~~Mr. ~~reasonable~~Simmermacher ~~access~~also toserved ~~diligence~~since ~~materials,~~2020 ~~making~~as ~~management~~a ~~available~~director ~~for~~of ~~discussions,~~Sitio ~~and~~0 de Quequén ~~facilitating~~S.A. ~~access~~Mr. toSimmermacher ~~facilities,~~received ~~all~~an ~~subject~~Executive toMBA ~~appropriate~~from ~~confidentiality~~IAE ~~protections~~Business School and ~~operational~~a ~~requirements~~degree in Industrial Engineering from Instituto Tecnológico de Buenos Aires.

~~While~~Mr. ~~the~~Narain ~~Company~~has ~~agreed~~served ~~that~~as a non-executive director of RiceTec, Inc. since ~~the~~2025 ~~adjournment~~and isas ~~necessary~~an toindependent ~~ensure~~non-executive adirector ~~commercially~~of ~~reasonable~~Medi ~~sale,~~Assist ~~the~~Healthcare ~~Company~~Services ~~has~~Ltd. ~~not~~since ~~waived~~2024. orMr. ~~limited~~Narain ~~any~~is ~~argument,~~also ~~claim,~~a orfounding ~~defense~~partner of AgVaya an organisation that collaborates with ~~respect~~agri businesses, food companies and developmental organizations to ~~the~~create ~~conduct~~sustainable opportunities ofand ~~the~~drive ~~sale~~growth in smallholder agricultural markets. Mr. Narain served as vice chairman, ~~the~~managing ~~commercial~~director ~~reasonableness~~and chief executive officer of ~~the~~Bayer ~~sale~~CropScience Limited from December 2018 to October 2023, orand ~~the~~concurrently ~~propriety~~as president at Bayer South Asia and global head of ~~the~~smallholder ~~sale~~farming at Bayer. ~~The~~He ~~Company’s~~previously served ~~agreement~~as tovice ~~cooperate~~president ~~does~~and ~~not~~treasurer ~~constitute~~of anMonsanto ~~admission~~Company offrom ~~liability~~November 2015 to October 2018, aand ~~waiver~~held ofvarious ~~any~~senior ~~defenses~~finance toand ~~the~~commercial roles ~~alleged~~at ~~defaults~~Monsanto from 1998, orincluding achief ~~concession regarding~~executive ~~the~~officer ~~Defendant~~of Monsanto’s ~~claims~~India region. ~~The~~Mr. ~~Company~~Narain ~~continues~~received toan ~~dispute~~MBA from the ~~alleged~~Kellogg School ~~defaults~~of ~~and~~Management ~~preserve~~at ~~its~~Northwestern ~~rights~~University, tois ~~challenge~~a chartered accountant from the ~~proceedings~~ ~~and~~Institute ~~any~~of ~~sale~~Chartered ~~process~~Accountants ~~that~~of ~~may~~India, ~~not~~and ~~comply~~holds a ~~with~~Bachelor ~~applicable~~of ~~legal~~Commerce ~~requirements~~degree from the University of Madras.

Natalia Zang, who has served as a director since February 2019, has resigned from the Board of Directors with effect from December 26, 2025. The Company sincerely appreciates Ms. Zang’s years of dedicated service to the Board of Directors and the experience and expertise she provided to the Company and its shareholders, with contributions which have been instrumental in guiding the Company through a period of significant growth and transformation. Mr. Narain will fill the resulting vacancy and will serve on the committees previously composed by Ms. Zang, including as chair of the audit committee.

The Company currently expects to mail the proxy materials to its shareholders in January 2026 and to hold its annual general meeting as soon as practical thereafter. The Company intends to propose the reappointment of the current members of its Board of Directors to serve as directors through its 2027 annual general meeting.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	BIOCERES CROP SOLUTIONS CORP.
	(Registrant)
Dated: December 22, 2025	By:	/s/ Federico Trucco
Dated: December 31, 2025	By:	/s/ Federico Trucco
	Name:	Federico Trucco
	Title:	Chief Executive Officer

Filing Compare · Bioceres Crop Solutions Corp.